ERBB2 and neoplasm: Treatment of mice with s.c. MDA-MB-361 tumours with HER2-targeted AuNPs combined with 11 Gy of XRT decreased tumour volume by ~ twofold over 5 weeks, while tumours treated with only XRT increased in size.